JP2014526519A5 - - Google Patents

Download PDF

Info

Publication number
JP2014526519A5
JP2014526519A5 JP2014530924A JP2014530924A JP2014526519A5 JP 2014526519 A5 JP2014526519 A5 JP 2014526519A5 JP 2014530924 A JP2014530924 A JP 2014530924A JP 2014530924 A JP2014530924 A JP 2014530924A JP 2014526519 A5 JP2014526519 A5 JP 2014526519A5
Authority
JP
Japan
Prior art keywords
range
pharmaceutical composition
mdj
nanocarriers
size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014530924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014526519A (ja
Filing date
Publication date
Priority claimed from PCT/IB2012/000364 external-priority patent/WO2012114196A1/pt
Application filed filed Critical
Priority claimed from PCT/US2012/055757 external-priority patent/WO2013040556A1/en
Publication of JP2014526519A publication Critical patent/JP2014526519A/ja
Publication of JP2014526519A5 publication Critical patent/JP2014526519A5/ja
Pending legal-status Critical Current

Links

JP2014530924A 2011-09-16 2012-09-17 ジャスモネート化合物の組成物および使用方法 Pending JP2014526519A (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201161535836P 2011-09-16 2011-09-16
US61/535,836 2011-09-16
US201161555690P 2011-11-04 2011-11-04
US61/555,690 2011-11-04
US201261603042P 2012-02-24 2012-02-24
US61/603,042 2012-02-24
IBPCT/IB2012/000364 2012-02-27
PCT/IB2012/000364 WO2012114196A1 (pt) 2011-02-25 2012-02-27 Formulação farmacêutica compreendendo compostos da família dos jasmonatos
US201261607318P 2012-03-06 2012-03-06
US61/607,318 2012-03-06
US201261612774P 2012-03-19 2012-03-19
US61/612,774 2012-03-19
PCT/US2012/055757 WO2013040556A1 (en) 2011-09-16 2012-09-17 Compositions of jasmonate compounds and methods of use

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2017117103A Division JP2017222659A (ja) 2011-09-16 2017-06-14 ジャスモネート化合物の組成物および使用方法
JP2019000256A Division JP2019077702A (ja) 2011-09-16 2019-01-04 ジャスモネート化合物の組成物および使用方法

Publications (2)

Publication Number Publication Date
JP2014526519A JP2014526519A (ja) 2014-10-06
JP2014526519A5 true JP2014526519A5 (enExample) 2015-11-12

Family

ID=47883826

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014530924A Pending JP2014526519A (ja) 2011-09-16 2012-09-17 ジャスモネート化合物の組成物および使用方法
JP2017117103A Pending JP2017222659A (ja) 2011-09-16 2017-06-14 ジャスモネート化合物の組成物および使用方法
JP2019000256A Pending JP2019077702A (ja) 2011-09-16 2019-01-04 ジャスモネート化合物の組成物および使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017117103A Pending JP2017222659A (ja) 2011-09-16 2017-06-14 ジャスモネート化合物の組成物および使用方法
JP2019000256A Pending JP2019077702A (ja) 2011-09-16 2019-01-04 ジャスモネート化合物の組成物および使用方法

Country Status (11)

Country Link
US (3) US8883220B2 (enExample)
EP (1) EP2755643B1 (enExample)
JP (3) JP2014526519A (enExample)
KR (2) KR102023132B1 (enExample)
CN (2) CN107970213A (enExample)
BR (1) BR112014006153A2 (enExample)
CA (1) CA2848219A1 (enExample)
HK (1) HK1254825A1 (enExample)
MX (1) MX370253B (enExample)
RU (1) RU2014114931A (enExample)
WO (1) WO2013040556A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013021670A2 (pt) * 2011-02-25 2016-11-01 Nanocare Technologies Inc formulação farmacêutica compreendendo compostos derivados do metabolismo, catabolismo dos elementos das famílias dos jasmonatos e seus derivados carreados em micro e/ou nanocarreadores
RU2014114931A (ru) * 2011-09-16 2015-10-27 Нанокэа Текнолоджиз, Инк. Композиции соединений жасмонатов и способы применения
JP2014122191A (ja) * 2012-12-21 2014-07-03 L'oreal Sa 油、非イオン界面活性剤及びジャスモン酸誘導体を含む化粧品組成物
US11166886B2 (en) 2012-12-21 2021-11-09 L'oreal Cosmetic composition
US20150230462A1 (en) * 2014-01-15 2015-08-20 New Biology, Inc. Methods for improving germination and stress tolerance characteristics with jasmonates
US10314918B2 (en) 2014-12-31 2019-06-11 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof
CN108778263A (zh) * 2016-03-28 2018-11-09 维达克制药有限公司 用于局部用药的稳定药物组合物及其用途
US10410943B2 (en) 2016-10-13 2019-09-10 Asm Ip Holding B.V. Method for passivating a surface of a semiconductor and related systems
US11266639B2 (en) * 2016-11-07 2022-03-08 Vidac Pharma Ltd. Use of hexokinase 2/mitochondria-detaching compounds for treating hexokinase-2 (HK2)-expressing cancers
WO2018083704A1 (en) 2016-11-07 2018-05-11 Vidac Pharma Ltd. Use of hexokinase 2/mitochondria-detaching compounds for activating immune responses
CA3096327A1 (en) * 2018-04-12 2019-10-17 Vytrus Biotech, S.L. Abscisic acid for the treatment of skin diseases
KR102275801B1 (ko) * 2019-12-24 2021-07-09 경희대학교 산학협력단 시스-자스몬을 포함하는 바이오필름 형성 억제용 조성물

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0392608T3 (da) 1989-04-12 1995-11-20 Procter & Gamble Faste konsumentproduktsammensætninger, der indeholder cyclodextrinkomplekser af lille partikelstørrelse
CA2013485C (en) 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
JP3568325B2 (ja) * 1996-07-12 2004-09-22 株式会社ノエビア 抗アンドロゲン剤及び養毛剤並びに毛髪用化粧料
JP3596835B2 (ja) 1996-08-13 2004-12-02 株式会社ノエビア 養毛剤
JP2002504118A (ja) 1997-06-09 2002-02-05 ザ、プロクター、エンド、ギャンブル、カンパニー 体臭および過剰湿気を軽減する芳香組成物および方法
US6790815B1 (en) 1998-07-10 2004-09-14 Procter & Gamble Company Amine reaction compounds comprising one or more active ingredient
CA2274873A1 (en) 1999-07-06 2001-01-06 Satinder Gidda Methods and compositions for modulating flowering
AU2002245629A1 (en) 2001-03-08 2002-09-24 Targesome, Inc. Stabilized therapeutic and imaging agents
US6469061B1 (en) 2001-04-04 2002-10-22 Ramot University Authority For Applied Research And Industrial Development Limited Jasmonate pharmaceutical composition for treatment of cancer
US20030224024A1 (en) 2002-02-04 2003-12-04 Jean-Luc Leveque Compositions comprising cyclopentane derivatives and their use
US20040209795A1 (en) * 2003-04-21 2004-10-21 Vlad Florin Joseph VOC-free microemulsions
CN1902156A (zh) 2003-12-02 2007-01-24 雷蒙特亚特特拉维夫大学有限公司 茉莉酮酸酯衍生化合物、药物组合物及其使用方法
KR100789343B1 (ko) 2004-09-07 2007-12-28 주식회사 엘지생활건강 화장용 분체, 그의 제조방법 및 이를 함유하는 메이컵화장품 조성물
US20080044364A1 (en) 2004-11-25 2008-02-21 Christophe Carola Flavonoid Complexes
US7258878B2 (en) 2004-12-20 2007-08-21 Kimberly-Clark Worldwide, Inc. Anti-microbial composition and methods of use thereof
ES2265291B1 (es) 2005-07-22 2008-03-01 Universidad De Alcala Nuevos dendrimeros carbosilanos, su preparacion y sus usos.
WO2007066337A2 (en) 2005-12-07 2007-06-14 Sepal Pharma Ltd. Jasmonate derivatives, pharmaceutical compositions and methods of use thereof
US20090291904A1 (en) 2005-12-07 2009-11-26 Yoel Kashman Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
WO2007103336A2 (en) 2006-03-06 2007-09-13 The Board Of Trustees Operating Micro-encapsulation of volatile compounds into cyclodextrins
US20090185985A1 (en) 2006-06-13 2009-07-23 Cargill, Incorporated Large-particle cyclodextrin inclusion complexes and methods of preparing same
AU2007273809A1 (en) 2006-07-10 2008-01-17 Ramot At Tel-Aviv University Ltd. Combination methods of treating cancer
BRPI0604024A (pt) 2006-09-01 2008-04-22 Beyond Lifescience Pesquisa De alimentos para a prevenção do cáncer e composições farmacêuticas à base do jasmonato
EP2049083A2 (en) 2006-12-27 2009-04-22 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
WO2009019693A2 (en) 2007-08-07 2009-02-12 Sepal Pharma Sa Analgesic effect of jasmonate derivatives
SI2200588T1 (sl) 2007-09-25 2019-08-30 Solubest Ltd. Sestavki, ki obsegajo lipofilne aktivne spojine, in postopek za njihovo pripravo
GB0721761D0 (en) 2007-11-06 2007-12-19 Plant Bioscience Ltd Compositions and methods for synergistic manipulation of plant and insect defences
US20090133166A1 (en) 2007-11-19 2009-05-21 New Biology, Inc. Methods for Improving Flowering Characteristics Using Methyl Dihydrojasmonate
US20090197939A1 (en) * 2008-02-01 2009-08-06 Mary Kay Inc. Methods of treating skin with aromatic skin-active ingredients
ES2328002B2 (es) 2008-02-29 2010-03-29 Universidad De Alicante Uso combinado de metil-jasmonato y ciclodextrinas para la produccion de resveratrol.
BRPI0804172A2 (pt) * 2008-07-15 2010-07-06 Pereira Lopes Jose Emilio Fehr compostos quìmicos formados a partir de nanoencapsulamentos e complexação de elementos
AU2010258223B2 (en) * 2009-06-09 2014-12-04 Ramot At Tel-Aviv University Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
CN101818100B (zh) * 2010-04-15 2012-06-06 上海应用技术学院 聚氰基丙烯酸丁酯包覆大花茉莉香精胶囊的制备方法
ES2600928T3 (es) 2010-08-27 2017-02-13 Neonc Technologies Inc. Composiciones farmacéuticas que comprenden derivados de alcohol perilílico
BR112013021670A2 (pt) 2011-02-25 2016-11-01 Nanocare Technologies Inc formulação farmacêutica compreendendo compostos derivados do metabolismo, catabolismo dos elementos das famílias dos jasmonatos e seus derivados carreados em micro e/ou nanocarreadores
RU2014114931A (ru) 2011-09-16 2015-10-27 Нанокэа Текнолоджиз, Инк. Композиции соединений жасмонатов и способы применения
EP2583998B1 (en) * 2011-10-21 2018-02-28 Borealis AG Polyethylene composition with high rapid crack propagation resistance and pressure resistance
US9187402B2 (en) 2012-06-14 2015-11-17 North Carolina Agricultural And Technical State University Aspirin derivatives and uses thereof
AU2013288738A1 (en) 2012-07-10 2015-01-29 Baseclick Gmbh Anandamide-modified nucleic acid molecules
US10314918B2 (en) 2014-12-31 2019-06-11 Nanocare Technologies, Inc. Jasmonate derivatives and compositions thereof

Similar Documents

Publication Publication Date Title
Tabaei et al. Single vesicle analysis reveals nanoscale membrane curvature selective pore formation in lipid membranes by an antiviral α-helical peptide
Yuan et al. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles
Zinchenko et al. Single-chain compaction of long duplex DNA by cationic nanoparticles: modes of interaction and comparison with chromatin
HRP20200256T1 (hr) Čestice bilirubina i njihova priprema za uporabu u liječenju
JP2012085643A5 (enExample)
JP2011525477A5 (enExample)
JP2015525757A5 (enExample)
JP2015519403A5 (enExample)
JP2014513036A5 (enExample)
JP2012500004A5 (enExample)
ATE541909T1 (de) Klebstoff
JP2014523540A5 (enExample)
BRPI1013021A2 (pt) "material compósito que compreende nanopartículas, e produção de camadas fotoativas que contêm nanopartículas semicondutoras quaternárias, pentanárias ou de ordem mais alta"
Nam et al. Investigation of tacrolimus loaded nanostructured lipid carriers for topical drug delivery
JP2013535021A5 (enExample)
Sun et al. Sulfur nanoparticles with novel morphologies coupled with brain-targeting peptides RVG as a new type of inhibitor against metal-induced aβ aggregation
CR20150077A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
RU2014114931A (ru) Композиции соединений жасмонатов и способы применения
UA112540C2 (uk) Плівкова лікарська форма, яка містить вільну основу силденафілу, і спосіб її отримання
JP2013511602A5 (enExample)
AR075686A1 (es) Nanoparticulas de policosanol
JP2015510935A5 (enExample)
JP2014107143A5 (enExample)
Sikorska et al. Adverse Effects of Non-Metallic Nanoparticles in the Central Nervous System
JP2011251959A5 (enExample)